Skip to main content
Equibles
XRAY logo

XRAY · DENTSPLY SIRONA Inc.

Track XRAY — free

Use XRAY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$11.38 -0.05 (-0.44%) At close · Sep 4
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.28B
Shares
199.35M

XRAY metrics

84 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.38
Market cap
$2.28B

Price action

19 metrics
Price change (1W)
+2.3%
Price change (30D)
-13.6%
Price change (3M)
+13.8%
Price change (6M)
-10.7%
Price change (YTD)
-0.4%
Price change (1Y)
-20.6%
Trailing year
Price change (5Y)
-81.8%
52-week high
$14.68
52-week low
$9.64
Change from 52-week high
-22.5%
Change from 52-week low
+18.0%
Annualized volatility
46.2%
Beta
1.3
RSI (14D)
47.2
Price vs SMA 50
-6.3%
Price vs SMA 200
-3.0%
Avg volume (3M)
5.02M
Relative volume
0.5
Average dollar volume
$59.16M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
199.35M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 159.9%
P / book
1.7
reciprocal yield 59.3%
FCF yield
6.3%
TTM · current market cap
Buyback yield
—
P / FCF
15.9
reciprocal yield 6.3%
P / operating cash flow
7.1
reciprocal yield 14.0%
Earnings yield
-23.9%

Historical valuation

8 metrics
P / E historical average (3Y)
53.4×
reciprocal yield 1.9%
P / E historical average (5Y)
53.4×
reciprocal yield 1.9%
EV / revenue historical average (3Y)
1.5×
reciprocal yield 65.5%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 56.3%
EV / EBIT historical average (3Y)
118.6×
reciprocal yield 0.8%
EV / EBIT historical average (5Y)
118.6×
reciprocal yield 0.8%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.8%
Trailing 12 months
Payout ratio
—
Shareholder yield
4.2%
Dividend / share (TTM)
$0.32
Dividend growth YoY
-50.0%
Dividend growth streak
—
Last ex-dividend
2025-12-26

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
49.5%
Operating margin
-8.5%
Trailing 12 months
Net margin
-15.0%
Gross profit (TTM)
$1.80B
Operating profit (TTM)
−$310.00M
Net income (TTM)
−$545.00M
Trailing 12 months
Diluted EPS (TTM)
$-2.75
FCF margin
3.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$10.69

Growth

11 metrics
Revenue growth YoY
-4.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.64B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.6%
Year over year · more shares
Revenue CAGR (3Y)
-2.1%
Revenue CAGR (5Y)
+2.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-34.4%
FCF CAGR (5Y)
-28.6%

Quality

14 metrics
Return on equity
-40.3%
Return on assets
-10.5%
Debt / equity
1.6
Current ratio
1.6
EBITDA (TTM)
$39.00M
Free cash flow (TTM)
$143.00M
Quick ratio
1.1
Interest coverage
-3.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$239.00M
Total assets
$5.20B
Total debt
$2.22B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$319.00M
Capital expenditures (TTM)
$176.00M
R&D (TTM)
$166.00M
SG&A (TTM)
$1.45B
Stock compensation (TTM)
$31.00M
R&D / revenue
4.6%
Stock compensation / revenue
0.9%

Ownership (13F)

3 metrics
13F filers
374
13F filer change QoQ
-11
Institutional ownership
113.7%

Short interest

3 metrics
Short interest
9.9%
Latest settlement · 3.8 days to cover
Days to cover
3.8d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
$617,199
Insider-sentiment score
90 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 818479 CUSIP 24906P109 13F (30d) 261 filings 251 filers Visit website Investor relations